INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Running, not enrolling · Phase 1
Conditions studied: BRCA1/2 Mutation
In brief
The research study is being conducted to test an experimental vaccine to potentially prevent cancer for people with BRCA1 or BRCA2 mutations. This study will test if the vaccine is safe (without significant side effects) and test a new way of administering vaccines. It will also test whether the vaccine activates your immune system.
Key facts
- Study ID
- NCT04367675
- Run by
- Abramson Cancer Center at Penn Medicine
- People needed
- 44
- Starts
- 2021-04-20
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2026-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.